Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Long Meng

Showing results (341-350 of 358) with videos related to

Pageof 36
Sort By:
Leukemia|April 24, 2023
Targeting DNA polymerase β elicits synthetic lethality with mismatch repair deficiency in acute lymphoblastic leukemiaJi-Yuan Teng, Ding-Peng Yang, Chao Tang, et al.
Nature Communications|November 12, 2021
Focal amplifications are associated with chromothripsis events and diverse prognoses in gastric cardia adenocarcinomaXue-Ke Zhao, Pengwei Xing, Xin Song, et al.
Science Advances|May 15, 2026
Controlling thermoreversibility and hole conductivity in thermoresponsive ionic biogels using phase morphology for neurohapticsAnkan Dutta, Md Abu Sayeed Biswas, Ethan Gerhard, et al.
Nature|June 25, 2025
Mechanism of cytarabine-induced neurotoxicityJia-Cheng Liu, Dongpeng Wang, Elsa Callen, et al.
Molecular Cell|March 6, 2025
Transcription-coupled AID deamination damage depends on ELOF1-associated RNA polymerase IIPengfei Dai, Yuanqing Tan, Yifeng Luo, et al.
Cancer Letters|July 6, 2026
FGFR2 Fusion-Driven CXCL3 Downregulation Attenuates Neutrophil Recruitment in Intrahepatic CholangiocarcinomaTao Zhu, Jia-Cheng Lu, Yan-Zi Pei, et al.
Nature Cell Biology|February 7, 2018
The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168Xiaoduo Xie, Hongli Hu, Xinyuan Tong, et al.
Hepatology International|November 23, 2022
The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasionXian-Long Meng, Jia-Cheng Lu, Hai-Ying Zeng, et al.
Signal Transduction and Targeted Therapy|March 17, 2023
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 studyGuo-Ming Shi, Xiao-Yong Huang, Dong Wu, et al.
Frontiers in Immunology|September 16, 2021
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic CholangiocarcinomaXiao-Jun Guo, Jia-Cheng Lu, Hai-Ying Zeng, et al.
Pageof 36

Showing results (341-350 of 358) with videos related to

Sort By:
Pageof 36
Leukemia|April 24, 2023
Targeting DNA polymerase β elicits synthetic lethality with mismatch repair deficiency in acute lymphoblastic leukemiaJi-Yuan Teng, Ding-Peng Yang, Chao Tang, et al.
Nature Communications|November 12, 2021
Focal amplifications are associated with chromothripsis events and diverse prognoses in gastric cardia adenocarcinomaXue-Ke Zhao, Pengwei Xing, Xin Song, et al.
Science Advances|May 15, 2026
Controlling thermoreversibility and hole conductivity in thermoresponsive ionic biogels using phase morphology for neurohapticsAnkan Dutta, Md Abu Sayeed Biswas, Ethan Gerhard, et al.
Nature|June 25, 2025
Mechanism of cytarabine-induced neurotoxicityJia-Cheng Liu, Dongpeng Wang, Elsa Callen, et al.
Molecular Cell|March 6, 2025
Transcription-coupled AID deamination damage depends on ELOF1-associated RNA polymerase IIPengfei Dai, Yuanqing Tan, Yifeng Luo, et al.
Cancer Letters|July 6, 2026
FGFR2 Fusion-Driven CXCL3 Downregulation Attenuates Neutrophil Recruitment in Intrahepatic CholangiocarcinomaTao Zhu, Jia-Cheng Lu, Yan-Zi Pei, et al.
Nature Cell Biology|February 7, 2018
The mTOR-S6K pathway links growth signalling to DNA damage response by targeting RNF168Xiaoduo Xie, Hongli Hu, Xinyuan Tong, et al.
Hepatology International|November 23, 2022
The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasionXian-Long Meng, Jia-Cheng Lu, Hai-Ying Zeng, et al.
Signal Transduction and Targeted Therapy|March 17, 2023
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 studyGuo-Ming Shi, Xiao-Yong Huang, Dong Wu, et al.
Frontiers in Immunology|September 16, 2021
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic CholangiocarcinomaXiao-Jun Guo, Jia-Cheng Lu, Hai-Ying Zeng, et al.
Pageof 36